MAPT and Alzheimer disease: The acknowledged biomarkers in cerebrospinal fluid (CSF) include Aβ, total tau (T-tau), and phosphorylated tau (P-tau; Olsson et al., 2016), but we found it difficult to distinguish AD from controls due to the nonspecific changes in AD.